Who benefits from Helicobacter pylori eradication?
- PMID: 16439372
- PMCID: PMC1352037
- DOI: 10.1136/bmj.332.7535.187
Who benefits from Helicobacter pylori eradication?
Comment on
-
Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.BMJ. 2006 Jan 28;332(7535):199-204. doi: 10.1136/bmj.38702.662546.55. Epub 2006 Jan 20. BMJ. 2006. PMID: 16428249 Free PMC article. Clinical Trial.
Similar articles
-
Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.Am J Gastroenterol. 2001 Feb;96(2):338-47. doi: 10.1111/j.1572-0241.2001.03516.x. Am J Gastroenterol. 2001. PMID: 11232673
-
Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.BMJ. 2006 Jan 28;332(7535):199-204. doi: 10.1136/bmj.38702.662546.55. Epub 2006 Jan 20. BMJ. 2006. PMID: 16428249 Free PMC article. Clinical Trial.
-
The case for Helicobacter pylori eradication in India: sensationalism, skepticism and scientific salesmanship.Indian J Gastroenterol. 2006 Jan-Feb;25(1):20-4. Indian J Gastroenterol. 2006. PMID: 16567890 Review. No abstract available.
-
Helicobacter pylori serology in evaluation of dyspepsia.Am Fam Physician. 1998 Feb 15;57(4):631-2. Am Fam Physician. 1998. PMID: 9490986 No abstract available.
-
Long-term consequences of Helicobacter pylori eradication: clinical aspects.Scand J Gastroenterol Suppl. 1996;215:111-5. Scand J Gastroenterol Suppl. 1996. PMID: 8722393 Review.
Cited by
-
In Vitro Inhibition of Helicobacter pylori Growth by Redox Cycling Phenylaminojuglones.Oxid Med Cell Longev. 2018 Apr 24;2018:1618051. doi: 10.1155/2018/1618051. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29849864 Free PMC article.
References
-
- Talley NJ. Review article: dyspepsia: how to manage and how to treat? Aliment Pharmacol Ther 2005;16: 95-104. - PubMed
-
- Chiba N, Veldhuyzen van Zanten SJ, Sinclair P, Ferguson RA, Escobedo S. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dypsepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ 2002;324: 1012-5. - PMC - PubMed
-
- Mason JM, Delaney B, Moayyedi P, Thomas M, Walt R, North of England Dyspepsia Guideline Development Group. Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales. Aliment Pharmacol Ther 2005;21: 1135-43. - PubMed
-
- Ford A, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev 2003(4): CD003840. - PubMed
-
- Moayyedi P, Deeks JJ, Talley NJ, Delaney BC, Forman D. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between the systematic reviews. Am J Gastroenterol 2003;98: 2621-6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical